Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- EVO301Phase 21 trial
Evommune, Inc. · Atopic Dermatitis (AD), Eczema, Eczema Atopic Dermatitis
- EVX-01Phase 21 trial
Evaxion Biotech A/S · Melanoma Stage IV, Unresectable Melanoma
- EX039Phase 21 trial
Excelsior · Alzheimer Disease
- EX103Phase 21 trial
Guangzhou Excelmab Inc. · CD20-positive Non-Hodgkin Lymphoma
- EXE-346Phase 21 trial
Exegi Pharma, LLC · Ileal Pouch
- EXG110Phase 21 trial
Guangzhou Jiayin Biotech Ltd · Fabry Disease
- EXG202Phase 21 trial
Guangzhou Jiayin Biotech Ltd · Wet Age-related Macular Degeneration
- exidavnemabPhase 21 trial
BioArctic AB · Parkinson Disease, Multiple System Atrophy
- EXPD-101FXS7553Phase 21 trial
Expedition Therapeutics, Inc · Chronic Obstructive Pulmonary Disease (COPD)
- EXT608Phase 21 trial
Extend Biosciences Inc. · Hypoparathyroidism
- Extended PhasePhase 21 trial
Chengdu Zenitar Biomedical Technology Co., Ltd · Polycythemia Vera (PV)
- EYU688Phase 21 trial
Novartis · Dengue
- F182112Phase 21 trial
Shandong New Time Pharmaceutical Co., LTD · Relapsed or Refractory Multiple Myeloma
- F573Phase 21 trial
Beijing Continent Pharmaceutical Co, Ltd. · Acute Liver Failure, Acute-On-Chronic Liver Failure
- FamitinibSHR-1020Phase 21 trial
Jiangsu HengRui Medicine Co., Ltd. · Recurrent or Metastatic Cervical Cancer
- famzeretcelhuman retinal progenitor cells, jCellPhase 21 trial
jCyte, Inc · Retinitis Pigmentosa
- Farletuzumab ecteribulinMORAb-202Phase 21 trial
Eisai · Solid Tumor
- FB-1603Phase 21 trial
Febico Biomedical Corp. · Hepatocellular Carcinoma
- FB102Phase 21 trial
Forte Biosciences, Inc. · Celiac Disease
- FB704APhase 21 trial
Oneness Biotech Co., Ltd. · Severe Asthma
- FB849dose-escalation FB849, dose-expansion of FB849Phase 21 trial
1ST Biotherapeutics, Inc. · Advanced Solid Tumor
- FC084CSAPhase 21 trial
FindCure Biosciences (ZhongShan) Co., Ltd. · Advanced Malignant Solid Tumors
- FDC fianlimabPhase 21 trial
Regeneron · Head and Neck Squamous Cell Carcinoma (HNSCC)
- FF-10832Gemcitabine LiposomePhase 21 trial
Fujifilm Pharmaceuticals U.S.A., Inc. · Advanced Urothelial Carcinoma, Advanced Non Small Cell Lung Cancer
- FG-3246FOR46Phase 21 trial
Kyntra Bio · Metastatic Castration-Resistant Prostate Cancer
- FG001Optical imaging agent FG001, Fluorescent imaging agent FG001Phase 21 trial
FluoGuide A/S · High-Grade Glioma (WHO III-IV)
- FHND1002Phase 21 trial
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. · Amyotrophic Lateral Sclerosis (ALS)
- FID007Paclitaxel in Polyethyloxazoline Polymer, Nanoencapsulated Paclitaxel FID-007Phase 21 trial
Fulgent Pharma LLC. · Head and Neck Squamous Cell Carcinoma
- FinotonlimabPhase 21 trial
Sichuan Baili Pharmaceutical Co., Ltd. · Advanced Hepatocellular Carcinoma
- Fixed cemiplimabPhase 21 trial
Regeneron · Melanoma
- FluvustatPhase 21 trial
Shandong Suncadia Medicine Co., Ltd. · Advanced Unresectable or Metastatic Breast Cancer
- FluzoparibPhase 21 trial
Risen (Suzhou) Pharma Tech Co., Ltd. · Advanced Solid Tumors
- FLX475tivumecirnonPhase 21 trial
RAPT Therapeutics, Inc., a member of the GSK plc group of companies · Advanced Cancer
- FMC-242Phase 21 trial
Frontier Medicines Corporation · Locally Advanced Solid Tumor
- FNP-223Phase 21 trial
Ferrer Internacional S.A. · Progressive Supranuclear Palsy
- FOG-001Phase 21 trial
Parabilis Medicines, Inc. · Cancer, Colorectal Cancer, Solid Tumor
- ForalumabPhase 21 trial
Tiziana Life Sciences LTD · Secondary Progressive Multiple Sclerosis
- FrevecitinibPhase 21 trial
Kinaset Therapeutics Inc · Severe Asthma
- FT819Phase 21 trial
Fate Therapeutics · Lupus Nephritis, Systemic Lupus Erythematosus, SLE - Systemic Lupus Erythematosus
- FT839Phase 21 trial
Fate Therapeutics · ANCA-Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM), Rheumatoid Arthritis (RA)
- FWY003Phase 21 trial
Novartis · Geographic Atrophy Secondary to Age-related Macular Degeneration
- FXR0906Phase 21 trial
Fosun Pharmaceutical Industrial Development (Shenzhen) Co., Ltd. · sHTG, HTG With ASCVD (Diagnosed or at Increased Risk)
- FXS5626Phase 21 trial
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. · Active Non-anterior, Non-infectious Uveitis
- Ga-68-NGULPhase 21 trial
Cellbion Co., Ltd. · Prostate Cancer, mCRPC
- GAd-209-FSPPhase 21 trial
Nouscom SRL · Solid Tumor, Adult
- GAd20-209-FSPPhase 21 trial
Nouscom SRL · Solid Tumor, Adult
- GAL-101Phase 21 trial
Galimedix Therapeutics Inc · Geographic Atrophy of the Macula
- GarutadustatISM5411Phase 21 trial
InSilico Medicine Hong Kong Limited · Ulcerative Colitis
- gavo-celPhase 21 trial
TCR2 Therapeutics · Mesothelioma, Mesothelioma, Malignant, Mesothelioma; Pleura
- GB2064Phase 21 trial
Galecto Biotech AB · Myelofibrosis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.